Thousands of NHS cancer patients in England will access trials of personalised cancer vaccines at 30 hospitals through the Cancer Vaccine Launch Pad. The mRNA vaccines are designed to target and destroy remaining cancer cells, reducing recurrence risk. Elliot Pfebve, the first patient, received the treatment for bowel cancer at Birmingham's Queen Elizabeth Hospital.